News

As a family business nurturing the next generation and with our home in the heart of the beautiful Alps, we are committed to protecting the world we live in. That is why we have developed our comprehensive sustainability strategy aimed at contributing to biodiversity and supporting a more sustainable agriculture. As part of this sustainability initiative, our Research & Development team in Trieste has initiated a broad range of projects to promote sustainable agricultural practices.

As we celebrate Dr. Schär's 100th anniversary, we are initiating the ambitious Field100 project: our aim is to cultivate one of the most biodiverse fields ever seen in the South Tyrolean Alps. To learn more about the background of Field100, we spoke with two experts during the sowing of the 100 different varieties at the beginning of April. Marina Braida, Corporate R&I Manager for Raw Materials & Agricultural Projects at Dr. Schär and agronomist Dr. Manuel Pramsohler, from the Laimburg Research Centre, are both deeply involved in Field100 and explain to us the significance of the project.

Christmas is the most wonderful time of the year. During the holidays, there are many great traditions that ensure time with family and friends. In particular, the shared experience of enjoying good food is more in focus than any other time of the year. These shared moments of enjoyment are precious as they connect us. At Dr. Schär, we are convinced that it is only truly Christmas when we are all part of these moments. We want to unite people of diverse dietary needs and tastes at the dinner table. That is why our gluten free brand Schär is calling for a new Christmas tradition: We invite everyone to bake gingerbread cookies with different shapes, ages, genders, styles and sizes in order to celebrate the most inclusive Christmas!

At Dr. Schär, we take our responsibility as a manufacturer of gluten-free products very seriously. After all, a gluten-free diet is not only a question of taste, but also of trust. Our promise to consistently meet the highest standards of quality, safety and sustainability is reflected throughout the entire “filiera” (Italian for “value chain”). We accompany our products throughout their entire life cycle. Thanks to close cooperation with scientists, farmers and millers, we are involved in the filiera from seed research to the supermarket.

A true milestone in sustainable food packaging: Dr. Schär partners with Niederwieser Spa in developing the world’s first gluten-free bread packaging made with certified circular plastic. Through this collaboration, Dr. Schär, with its leading gluten-free brand Schär, trusts in the expertise of the food packaging specialist Niederwieser Spa to jointly offer an innovative and sustainable packaging solution while maintaining the taste, quality and safety of their products.

We are convinced that Dr. Schär’s success is fundamentally based on the commitment and expertise of our staff. That is why we support our associates in their professional and personal development, for example with our Intercompany Exchange program. True to the motto "When we grow as individuals, we grow as a company," our customized training courses and initiatives foster know-how and competencies while offering employees a wide range of opportunities for personal growth.

In December 2020, Dr. Philipp Schoeller took over the role of CEO at Dr. Schär, succeeding founder Ulrich Ladurner. Philipp Schoeller, who was previously Vice President at the world’s largest chocolate manufacturer Barry Callebaut, has a clear vision of the company’s future: “Our values are responsibility – progress – proximity. These are the guiding principles of our actions. We therefore aspire to be the market leader with our respective brands. This means strong and fast innovation. We need to identify trends early and implement them faster. In doing so, we will become more international, while at the same time taking local needs into account. This is only possible with a strong local presence and local teams,” says the CEO.

Dr. Schär and Desitin, a fully integrated pharmaceutical company focused on CNS (Central Nercvous System) disease and rare diseases, announced today that they have joined forces to promote the Kanso product portfolio. With this agreement, both companies aim to advance the dietary treatment of drug-resistant epilepsy or other conditions for which the ketogenic diet is recommended.

As of July 1, 2021, Dr. Schär will divest its Metabolic Nutrition unit in order to further concentrate on customer segments with special nutritional needs as well as gluten free nutrition. The company is thus parting with the brands Mevalia and Comidamed and its products for the treatment of inborn errors of metabolism. Both brands, as well as the manufacturing facility in Rosbach, Germany, will be acquired by Vitaflo Limited, a business unit of Nestlé Health Science.